MedPharm expands relationship with Novan on formulation science
23 Jul 2019New agreement allows MedPharm to react quickly to changes in requirements and makes full use of its comprehensive services for de-risking Novan’s product development.
MedPharm, a leader in topical and transdermal drug delivery, has expanded its relationship with biopharmaceutical company Novan.
MedPharm has previously supported Novan by testing the company’s unique formulations using its proprietary in vitro models to optimise Novan’s formulations and de-risk product development.
The newly expanded agreement between the companies will broaden the relationship to include development of formulations and selection of product candidates, cost-effective product target screening and the development of in vitro models focused on Novan’s nitric oxide product technology.
“MedPharm is delighted to be able to support Novan in advancing and broadening its product pipeline,” commented Eugene Ciolfi, MedPharm’s President & CEO. “Our new agreement allows us to react quickly to changes in requirements and makes full use of MedPharm’s comprehensive services for de-risking Novan’s product development”.
“Novan recognises MedPharm has in-depth experience in developing new topical products fit for commercialisation”, added Paula Brown Stafford, Novan’s President and Chief Operating Officer. “The team’s responsiveness, rigorous scientific approach and specialised knowledge makes MedPharm an ideal partner to help Novan achieve its objectives.”
Companies mentioned
Related news
.jpg)
HALIX starts operational production with new cGMP facility in Q4-2019
15 Aug 2019
The five-level production facility contains a state-of-the-art manufacturing line for viral vaccines and viral vectors and a separate protein manufacturing area with a capacity up to 1,000-L single-use bioreactors.
Read more.jpg)
Delivering complete aseptic vial handling solutions
14 Aug 2019
Bringing freeze drying and vial washing/sterilizing technologies together with advanced and comprehensive vial and syringe filling capabilities.
Read more
Hikma expands nasal spray capabilities
12 Aug 2019
Company acquires unit-dose nasal and sublingual spray manufacturing equipment, as well as two pipeline products.
Read more
How real-world data can revolutionise drug development
9 Aug 2019
Utilising the current data environment and its data pools for the benefit of advancing research.
Read more.jpg)
Sartorius launches new services for mammalian cell bank manufacturing
8 Aug 2019
Integrated package of new and established services saves time and minimizes risks.
Read more
Using mobile phones to fight Alzheimer’s disease
8 Aug 2019
Researchers study how radiofrequency electromagnetic fields could be used in Alzheimer’s disease therapy.
Read more
Cambrex to be acquired by the Permira funds
7 Aug 2019
The CDMO's shareholders will receive $60.00 per share in cash.
Read more.jpg)
Automation-compatible prepared culture media plate technology
6 Aug 2019
Thermo Fisher Scientific's SmartPlate format brings together Oxoid and Remel prepared culture media with a durable, universal plate design, helping customers to deliver accurate results across both automated and manual methods.
Read more
Colorcon to incorporate TruTag's edible 'optical barcodes' in tablet film coatings
6 Aug 2019
The benefits of this innovation include the ability to instantly and unequivocally authenticate products when suspect events.
Read more
Growing domestic manufacturing creates new opportunities for international pharma in the Middle East
5 Aug 2019
Opportunities abound at CPhI MEA and experts anticipate regional generic companies acting as CMOs for international companies looking to enter the region.
Read moreAre you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation